| Low neutralization of SARS-CoV-2 Omicron BA. 2.75. 2, BQ. 1.1 and XBB. 1 by parental mRNA vaccine or a BA. 5 bivalent booster C Kurhade, J Zou, H Xia, M Liu, HC Chang, P Ren, X Xie, PY Shi Nature medicine 29 (2), 344-347, 2023 | 399 | 2023 |
| Neutralization of ba. 4–ba. 5, ba. 4.6, ba. 2.75. 2, bq. 1.1, and xbb. 1 with bivalent vaccine J Zou, C Kurhade, S Patel, N Kitchin, K Tompkins, M Cutler, D Cooper, ... New England Journal of Medicine 388 (9), 854-857, 2023 | 151 | 2023 |
| Viperin restricts Zika virus and tick-borne encephalitis virus replication by targeting NS3 for proteasomal degradation C Panayiotou, R Lindqvist, C Kurhade, K Vonderstein, J Pasto, K Edlund, ... Journal of virology 92 (7), 10.1128/jvi. 02054-17, 2018 | 129 | 2018 |
| Neutralization against Omicron SARS-CoV-2 from previous non-Omicron infection J Zou, H Xia, X Xie, C Kurhade, RRG Machado, SC Weaver, P Ren, ... Nature communications 13 (1), 852, 2022 | 122 | 2022 |
| Neutralization and durability of 2 or 3 doses of the BNT162b2 vaccine against Omicron SARS-CoV-2 H Xia, J Zou, C Kurhade, H Cai, Q Yang, M Cutler, D Cooper, A Muik, ... Cell Host & Microbe 30 (4), 485-488. e3, 2022 | 92 | 2022 |
| Type I Interferon response in olfactory bulb, the site of tick-borne flavivirus accumulation, is primarily regulated by IPS-1 C Kurhade, L Zegenhagen, E Weber, S Nair, K Michaelsen-Preusse, ... Journal of neuroinflammation 13, 1-14, 2016 | 83 | 2016 |
| A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions Y Liu, X Zhang, J Liu, H Xia, J Zou, AE Muruato, S Periasamy, C Kurhade, ... Nature communications 13 (1), 4337, 2022 | 82 | 2022 |
| Neutralization of Omicron BA. 1, BA. 2, and BA. 3 SARS-CoV-2 by 3 doses of BNT162b2 vaccine C Kurhade, J Zou, H Xia, H Cai, Q Yang, M Cutler, D Cooper, A Muik, ... Nature communications 13 (1), 3602, 2022 | 81 | 2022 |
| Remdesivir and GS-441524 retain antiviral activity against Delta, Omicron, and other emergent SARS-CoV-2 variants J Pitts, J Li, JK Perry, V Du Pont, N Riola, L Rodriguez, X Lu, C Kurhade, ... Antimicrobial agents and chemotherapy 66 (6), e00222-22, 2022 | 70 | 2022 |
| Cell-type-and region-specific restriction of neurotropic flavivirus infection by viperin R Lindqvist, C Kurhade, JD Gilthorpe, AK Överby Journal of neuroinflammation 15, 1-11, 2018 | 59 | 2018 |
| Less neutralization evasion of SARS-CoV-2 BA. 2.86 than XBB sublineages and CH. 1.1 Y Hu, J Zou, C Kurhade, X Deng, HC Chang, DK Kim, PY Shi, P Ren, ... Emerging microbes & infections 12 (2), 2271089, 2023 | 48 | 2023 |
| Improved neutralization of Omicron BA. 4/5 J Zou, C Kurhade, S Patel, N Kitchin, K Tompkins, M Cutler, D Cooper, ... BA 4, 854-857, 2022 | 42 | 2022 |
| Neutralization of Omicron sublineages and Deltacron SARS-CoV-2 by three doses of BNT162b2 vaccine or BA. 1 infection C Kurhade, J Zou, H Xia, M Liu, Q Yang, M Cutler, D Cooper, A Muik, ... Emerging microbes & infections 11 (1), 1828-1832, 2022 | 41 | 2022 |
| Improved neutralization of Omicron BA. 4/5, BA. 4.6, BA. 2.75. 2, BQ. 1.1, and XBB. 1 with bivalent BA. 4/5 vaccine J Zou, C Kurhade, S Patel, N Kitchin, K Tompkins, M Cutler, D Cooper, ... BioRxiv, 2022.11. 17.516898, 2022 | 30 | 2022 |
| Correlation of severity of human tick-borne encephalitis virus disease and pathogenicity in mice C Kurhade, S Schreier, YP Lee, L Zegenhagen, M Hjertqvist, G Dobler, ... Emerging infectious diseases 24 (9), 1709, 2018 | 30 | 2018 |
| Cross-neutralization of Omicron BA. 1 against BA. 2 and BA. 3 SARS-CoV-2 J Zou, C Kurhade, H Xia, M Liu, X Xie, P Ren, PY Shi Nature communications 13 (1), 2956, 2022 | 29 | 2022 |
| PKR kinase directly regulates tau expression and Alzheimer's disease‐related tau phosphorylation L Reimer, C Betzer, RH Kofoed, C Volbracht, K Fog, C Kurhade, E Nilsson, ... Brain Pathology 31 (1), 103-119, 2021 | 29 | 2021 |
| Brain heterogeneity leads to differential innate immune responses and modulates pathogenesis of viral infections L Zegenhagen, C Kurhade, N Koniszewski, AK Överby, A Kröger Cytokine & growth factor reviews 30, 95-101, 2016 | 22 | 2016 |
| Determinants and mechanisms of the low fusogenicity and high dependence on endosomal entry of Omicron subvariants P Qu, JP Evans, C Kurhade, C Zeng, YM Zheng, K Xu, PY Shi, X Xie, ... MBio 14 (1), e03176-22, 2023 | 20 | 2023 |
| Reverse genetic systems of SARS-CoV-2 for antiviral research C Kurhade, X Xie, PY Shi Antiviral research 210, 105486, 2023 | 20 | 2023 |
